Bioethics

  • Home
  • About
  • Events
  • Bioethics Resources
    • Featured Articles
    • Academic Programs & Certificates
    • Bioethics Centers & Institutions
    • Bioethics Journals & Publications
    • Multimedia Resources
    • Bioethics 101 Resources
    • Book Reviews
    • Movie Reviews
    • Employment, Fellowships & Internships
  • Topics

Your global information source on bioethics news, issues, & events

  • Twitter
  • RSS
  • Artificial Intelligence
  • Biotech
  • Clinical / Medical
  • Cloning
  • Covid-19
  • Culture
  • Disability Ethics
  • Disaster Ethics
  • Education
  • Emerging Technologies
  • Employment / Fellowships / Internships
  • End of Life
  • Eugenics
  • Euthanasia / Suicide
  • Genetic Ethics
  • Geriatric & Aging
  • Global Bioethics
  • Healthcare
  • Human Dignity
  • Human Enhancement
  • Informed Consent
  • Journal Articles
  • Medical Tourism
  • Mental Health
  • Multimedia Resources
  • Nanotechnology
  • Neuroethics
  • Nursing
  • Organ Donation / Transplantation
  • Pediatric
  • Pharma
  • Public Health
  • Public Policy
  • Reproductive Ethics
  • Research Ethics
  • Reviews
  • Stem Cell Research
  • Synthetic Biology
  • Women's Health
Pharma

Pharma

October 28, 2026

She Trusted ChatGPT With Her Medication Decisions. It Cost Her Everything.

(NYT) – The chatbot helped a woman taper off a lifesaving drug and hide the plan from her doctors. Qun knew his daughter had at times tinkered with her medications because she didn’t like the side effects or thought they … Read More

Posted by Bioethics Pundit

Posted in Artificial Intelligence, highlights, Informed Consent, Neuroethics, News, Pharma



 
 

October 23, 2026

Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

(Ars Technica) – Personalized mRNA vaccines against melanoma—the deadliest form of skin cancer—reduced the risk of death or recurrence by 42 percent compared to standard treatment in a late-stage trial, pharmaceutical partners Merck and Moderna announced Thursday. The results are … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Genetic Ethics, highlights, News, Pharma



 
 

October 23, 2026

As Politicians Argue About China, US Patients Find Cutting-Edge Treatment There

(KFF Health News) – Sunvozertinib, made by Shanghai-based Dizal Pharmaceutical, isn’t the only treatment drawing patients to China. Americans, Europeans, and others are trekking there to enter clinical trials for CAR-T therapy, an area in which China is now a … Read More

Posted by Bioethics Pundit

Posted in Global Bioethics, highlights, Informed Consent, News, Pharma



 
 

October 22, 2026

Telehealth Giant Hims Wants to Test Every Dude for Low Testosterone

(Wired) – The company plans to offer testosterone replacement therapy, marking its first foray into prescribing controlled substances. Talk of testosterone deficiency is hard to escape these days, with podcasters and politicians obsessing over how to avoid a “low T” … Read More

Posted by Bioethics Pundit

Posted in highlights, Human Enhancement, Informed Consent, News, Pharma



 
 

October 15, 2026

Can GLP-1s heal the brain? Obesity drugs get a makeover for addiction and depression

(Nature) – Compounds inspired by the blockbuster weight-loss drugs are also being trialled for schizophrenia and Parkinson’s disease, among other conditions. The quest for GLP-1 drugs that can treat brain disorders is getting a fresh infusion of energy and funding. … Read More

Posted by Bioethics Pundit

Posted in highlights, Mental Health, Neuroethics, News, Pharma



 
 

October 15, 2026

Big Pharma Is Pouring Billions Into a New Class of ‘Protein Degrader’ Drugs

(WSJ) – Novel approaches go after 85% of disease drivers that researchers haven’t been able to attack A new class of medications—known as “protein degraders”—are showing promise in going after a certain kind of hard-to-target protein in diseased cells. Most … Read More

Posted by Bioethics Pundit

Posted in Biotech, highlights, News, Pharma



 
 

October 13, 2026

Life Is Asymmetric. The Scientists Who Figured Out Why Won the 2026 Nobel Prize in Chemistry

(Wired) – Henri Kagan and Kensō Soai designed chemical reactions producing only one of the two mirror-image forms of a molecule—an important finding for the synthesis of pharmaceuticals and other biological substances. Some molecules are chiral, meaning a molecule has … Read More

Posted by Bioethics Pundit

Posted in Biotech, General Bioethics, News, People, Pharma



 
 

October 9, 2026

Weight-loss drugs show signs of slowing biological aging, say drugmakers

(MIT Technology Review) – Drug giants Eli Lilly and Novo Nordisk say patients taking their drugs age less quickly, according to readouts from molecular “aging clocks.” Such clocks assess a person’s biological age by looking at changes to DNA that … Read More

Posted by Bioethics Pundit

Posted in Geriatric & Aging, highlights, News, Pharma



 
 

October 6, 2026

The Family Plan

(Atavist Magazine) – When a little girl in Iowa was diagnosed with a rare incurable disease, her parents and their community came together to help her. They wound up making medical history. To patients with severe rare diseases, the drugs … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, News, Pharma



 
 

October 1, 2026

How Did Christa Pike Survive Two Lethal Injections of Pentobarbital?

(NYT) – A catheter carrying the drug may not have delivered the doses to Ms. Pike’s bloodstream, experts said. The drug itself may have been degraded. The execution team went through at least seven needles trying to find a vein … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, News, Pharma



 
 

October 1, 2026

The Next Frontier for Obesity Drugs Isn’t How Much Weight You Lose, but What Kind

(WSJ) – Drugmakers targeting muscle preservation and fat loss as they build next generation of weight-loss medications For as long as drugmakers have been testing weight-loss drugs, the question has been: How much weight do people lose? Now it is … Read More

Posted by Bioethics Pundit

Posted in News, Pharma



 
 

September 25, 2026

What GLP-1 users should know about the potential risk of a rare type of vision loss

(ABC News) – Dozens of Americans have filed personal injury lawsuits against the makers of popular GLP-1 drugs, like Ozempic, Wegovy and Mounjaro, claiming they were not properly warned of the risk of a rare type of sudden vision loss, … Read More

Posted by Bioethics Pundit

Posted in highlights, Informed Consent, News, Pharma



 
 

September 23, 2026

A new battery could make edible electronics safer

(The Economist) – Its components dissolve once it has done its job DEVICES THAT peer into the human body from the outside, like X-ray scanners and MRI machines, have transformed medicine. A new generation of ingestible sensors could do the … Read More

Posted by Bioethics Pundit

Posted in Emerging Technologies, News, Pharma



 
 

September 21, 2026

Novo Nordisk Will Use Anthropic’s Claude for Drug Research

(WSJ) – The Ozempic maker is partnering with the artificial-intelligence firm to speed up drug development Novo Nordisk, the Danish drugmaker behind blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, is partnering with Anthropic to use artificial intelligence for drug … Read More

Posted by Bioethics Pundit

Posted in Artificial Intelligence, highlights, News, Pharma, Research Ethics



 
 

September 16, 2026

Those Viral Bodega Peptides Aren’t Actually Peptides

(Wired) – WIRED tested samples of four types of peptides. The results show how lightly regulated the industry is, even as popularity surges. WIRED sent the vials to Finnrick, an Austin-based startup that offers independent peptide testing. Consumers can request … Read More

Posted by Bioethics Pundit

Posted in Informed Consent, News, Pharma



 
 

September 15, 2026

Drug firms’ secret data supercharge AI protein models

(Nature) – An AI system trained on more than 20,000 protein structures from pharmaceutical companies outperforms AlphaFold-like models that use only public data. For drug discovery, protein-folding models such as AlphaFold have a problem: there aren’t enough data in public … Read More

Posted by Bioethics Pundit

Posted in Artificial Intelligence, Emerging Technologies, highlights, News, Pharma, Research Ethics



 
 

September 14, 2026

A Teen Autopsy Marks the Arrival of a Deadly Drug in San Francisco

(NYT) – City officials — and one determined mother — are working to stop the spread of cychlorphine, which is far more potent than fentanyl. The death occurred in Ms. Lacourte’s three-bedroom apartment in the affluent Lower Nob Hill neighborhood … Read More

Posted by Bioethics Pundit

Posted in highlights, News, Pharma, Public Health



 
 

September 14, 2026

One State’s Battle to Stop People From Taking Unapproved Weight-Loss Drugs

(WSJ) – As bootleg versions of an experimental drug from Eli Lilly flood the market, regulators try to curb supply Clinics and medspas, promising people transformational weight loss, have figured out how to procure and sell an experimental drug that … Read More

Posted by Bioethics Pundit

Posted in highlights, Informed Consent, News, Pharma



 
 

September 11, 2026

The Race for the Next Big Weight-Loss Drug Is On—and China Wants In

(WSJ) – Long a maker of low-end generic drugs, the country is now home to biotech firms that are innovating fast Today Eli Lilly and Novo Nordisk, with drugs like Mounjaro and Ozempic, are the undisputed leaders of the $80-billion … Read More

Posted by Bioethics Pundit

Posted in Global Bioethics, highlights, News, Pharma



 
 

September 10, 2026

Early Data Indicates an A.I.-Generated Drug Could Slow Aging

(NYT) – Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age. Last year, a clinical trial conducted by Insilico … Read More

Posted by Bioethics Pundit

Posted in Artificial Intelligence, Emerging Technologies, highlights, Human Enhancement, News, Pharma



 
 

September 8, 2026

Another Heart Drug Fails, Shocking Cardiologists

(NYT) – Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease. Novartis announced on Friday that its experimental drug, pelacarsen, widely … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, News, Pharma



 
 

September 7, 2026

Study Suggests AI-Generated Drug Could Slow Aging

(Gizmodo) – An AI-generated drug showed early signs of potentially slowing aging, according to a new study out today in Nature Biotechnology, possibly taking the first small step towards using AI to cure all the diseases tech companies companies keep … Read More

Posted by Bioethics Pundit

Posted in Artificial Intelligence, highlights, News, Pharma, Research Ethics



 
 

September 3, 2026

The HIV clinics that disappeared when American aid stopped

(Daily Nation) – For years, in various counties, small, low-profile HIV clinics operated almost like a separate world within Kenya’s health system, funded not by the National Treasury but by the United States government, and built, deliberately, to keep a … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Global Bioethics, highlights, News, Pharma, Public Health



 
 

September 2, 2026

China is changing the shape of global health. The terms are still up for negotiation

(Nature) – China is making waves in global health care. The country’s biotechnology companies are producing medicines at a speed and cost that has drawn interest from the world’s largest pharmaceutical groups. They manufacture drugs and medical equipment used across … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Global Bioethics, News, Op-Ed, Pharma



 
 

September 2, 2026

Inside the Perimenopause Industrial Complex

(Wired) – How an alliance of tech startups, MAHA operatives, and actual medical experts made millennial women the new face of hormone therapy. One might be forgiven for wondering what isn’t a symptom of perimenopause. No lab test can reveal … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, Mental Health, News, Pharma, Women's Health



 
 
Older posts
  • Recent News
  • Trending
  • 10/28/2026Superbugs Are Winning—and They’re Now Killing 50,000 Americans a Year
  • 10/28/2026Texas Children’s Hospital opens detransition clinic after $10 million Paxton settlement
  • 10/28/2026Texas sues OpenAI over ChatGPT safety claims and alleged harm to minors
  • 10/28/2026Can science make your dog live longer? Longevity craze comes to pets
  • 10/28/2026She Trusted ChatGPT With Her Medication Decisions. It Cost Her Everything.
More News
    • Artificial Intelligence
    • Biotech
    • Clinical / Medical
    • Cloning
    • Covid-19
    • Culture
    • Disability Ethics
    • Disaster Ethics
    • Education
    • Emerging Technologies
    • Employment / Fellowships / Internships
    • End of Life
    • Eugenics
    • Euthanasia / Suicide
    • Genetic Ethics
    • Geriatric & Aging
    • Global Bioethics
    • Healthcare
    • Human Dignity
    • Human Enhancement
      • Transhumanism
    • Informed Consent
    • Journal Articles
    • Medical Tourism
    • Mental Health
    • Multimedia Resources
    • Nanotechnology
    • Neuroethics
    • News
      • Op-Ed
    • Nursing
    • Organ Donation / Transplantation
    • Pediatric
    • Pharma
    • Public Health
    • Public Policy
    • Reproductive Ethics
    • Research Ethics
    • Reviews
      • Books
      • Movies
    • Stem Cell Research
    • Synthetic Biology
    • Women's Health
    Ad
    bioethics.com
    • Home
    • About
    • Events
    • Contact
    • Advertising

    bioethics.com © 2002–Present by CBHD is licensed under CC BY-NC-ND 4.0

    • Twitter
    • RSS

    A Project Of The Center for Bioethics & Human Dignity